News | April 16, 2024
Laurus Labs forms JV company
KRKA holds 51% and Laurus Labs holds 49% shareholding
KRKA holds 51% and Laurus Labs holds 49% shareholding
Laurus Labs has reported total income of Rs. 1197.35 crores during the period ended December 31, 2023
Laurus Labs has reported total income of Rs. 1226.23 crores during the period ended September 30, 2023
NexCAR19 is an indigenously developed CD19 targeted CAR-T cell therapy
The company has reported total income of Rs. 1185.39 crores during the period ended June 30, 2023
Laurus Labs has announced that the USFDA completed inspection of the formulations manufacturing facility Unit-2, APSEZ, Atchutapuram, Visakhapatnam, Andhra Pradesh.
This will enable the company to consume 100% of the solar energy to be supplied by Ethan Energy India Private Limited from their 10 MW Solar Energy plant
The observation is procedural in nature and the company will address the observation within stipulated timelines.
On the Capex front, the company has invested Rs. 416 crore in the first half and it is broadly in line with our guidance for the two years around Rs. 2,000 crore across all the subsidiaries and divisions
Laurus Labs Limited has reported consolidated financial results for the period ended September 30, 2021
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)